Different Effects of Carvedilol, Metoprolol, and Propranolol on Left Ventricular Remodeling After Coronary Stenosis or After Permanent Coronary Occlusion in Rats

作者: Hiroyuki Yaoita , Atsushi Sakabe , Kazuhira Maehara , Yukio Maruyama

DOI: 10.1161/HC0802.104503

关键词:

摘要: Background— Although carvedilol attenuates left ventricular (LV) remodeling in coronary occlusion-reperfusion, it is not known whether ischemic LV because of stenosis (CS) or permanent occlusion (CO). Methods and Results— We administered a vehicle, carvedilol, propranolol (2, 10, 30 mg/kg per day, each), metoprolol (6, 30, 90 day), bunazosin (0.2 1 orally for 12 weeks to total 608 rats with CS CO. In these groups the sham (n=40), we assessed function by echocardiography, severity, myocardial blood flow reserve, serum ascorbyl free radical, vitamin C. Both CO increased end-diastolic end-systolic diameters decreased ejection fraction. The 4 agents failed attenuate caused contrast, 3 β-blockers attenuated (P<0.01) tended increase CS. With similar pressure heart rate low...

参考文章(14)
Kouichi Nakagawa, Hiroyuki Kanno, Yutaka Miura, Detection and Analyses of Ascorbyl Radical in Cerebrospinal Fluid and Serum of Acute Lymphoblastic Leukemia Analytical Biochemistry. ,vol. 254, pp. 31- 35 ,(1997) , 10.1006/ABIO.1997.2372
Ferenc Follath, John G.F Cleland, Werner Klein, Richard Murphy, Etiology and response to drug treatment in heart failure Journal of the American College of Cardiology. ,vol. 32, pp. 1167- 1172 ,(1998) , 10.1016/S0735-1097(98)00400-8
Hiroo Hashimoto, Akira Kanda, Hideo Hubo, Makoto Tanaka, Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia. Journal of Cardiovascular Pharmacology. ,vol. 18, ,(1991) , 10.1097/00005344-199106184-00006
H SAITO, H TOGASHI, M YOSHIOKA, A Comparative Study of the Effects of α1-Adrenoceptor Antagonists on Sympathetic Function in Rats American Journal of Hypertension. ,vol. 9, ,(1996) , 10.1016/0895-7061(96)00292-0
Sumit Basu, Roxy Senior, Usha Raval, Reinhard van der Does, Thomas Bruckner, Avijit Lahiri, Beneficial Effects of Intravenous and Oral Carvedilol Treatment in Acute Myocardial Infarction A Placebo-Controlled, Randomized Trial Circulation. ,vol. 96, pp. 183- 191 ,(1997) , 10.1161/01.CIR.96.1.183
Kirkwood F. Adams, Stephanie H. Dunlap, Carla A. Sueta, Susan W. Clarke, James Herbert Patterson, Mary Beth Blauwet, Lynda R. Jensen, Lisa Tomasko, Gary Koch, Relation Between Gender, Etiology and Survival in Patients With Symptomatic Heart Failure Journal of the American College of Cardiology. ,vol. 28, pp. 1781- 1788 ,(1996) , 10.1016/S0735-1097(96)00380-4
Jay N Cohn, Michael B Fowler, Michael R Bristow, Wilson S Colucci, Edward M Gilbert, Vithal Kinhal, Steven K Krueger, Thierry Lejemtel, Kenneth A Narahara, Milton Packer, Sarah T Young, Terry L Holcslaw, Mary Ann Lukas, US Carvedilol Heart Failure Study Group, Safety and efficacy of carvedilol in severe heart failure Journal of Cardiac Failure. ,vol. 3, pp. 173- 179 ,(1997) , 10.1016/S1071-9164(97)90013-0
Kenichi Watanabe, Yoshimi Ohta, Mikio Nakazawa, Hiroshi Higuchi, Go Hasegawa, Makoto Naito, Koichi Fuse, Masahiro Ito, Satoru Hirono, Naohito Tanabe, Haruo Hanawa, Kiminori Kato, Makoto Kodama, Yoshifusa Aizawa, Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy British Journal of Pharmacology. ,vol. 130, pp. 1489- 1495 ,(2000) , 10.1038/SJ.BJP.0703450
Sumanth D. Prabhu, Bysani Chandrasekar, David R. Murray, Gregory L. Freeman, β-Adrenergic Blockade in Developing Heart Failure Effects on Myocardial Inflammatory Cytokines, Nitric Oxide, and Remodeling Circulation. ,vol. 101, pp. 2103- 2109 ,(2000) , 10.1161/01.CIR.101.17.2103